Marker Therapeutics, Inc.MRKREarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Marker Therapeutics, Inc. is a clinical-stage biotechnology firm focused on developing innovative T cell immunotherapies for cancer treatment. Its pipeline covers hematological malignancies and multiple solid tumors, operating primarily in the U.S. oncology market to address unmet medical needs for patients with limited treatment options.